Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Management
Volume 2019, Article ID 9394715, 11 pages
https://doi.org/10.1155/2019/9394715
Research Article

Locating the Site of Neuropathic Pain In Vivo Using MMP-12-Targeted Magnetic Nanoparticles

1Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228
2Biomedical Institute for Global Health Research and Technology, National University of Singapore, Singapore 117599
3Department of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228
4Department of Spine Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China
5Singapore Bioimaging Consortium, Singapore 138667
6Department of Orthopaedic Surgery, National University Hospital, National University Healthy System, Singapore 119228
7Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593
8Department of Chemistry, National University of Singapore, Singapore 117543
9Centre of Excellence in Behavioural Medicine, Nguyen Tat Thanh University, Ho Chi Minh City 70000, Vietnam
10Faculty of Education, Huaibei Normal University, Huaibei, Anhui 235000, China

Correspondence should be addressed to Syeda Fabeha Husain; ude.sun.u@1547510e

Received 16 November 2018; Revised 29 January 2019; Accepted 14 February 2019; Published 6 March 2019

Guest Editor: Ke Ma

Copyright © 2019 Syeda Fabeha Husain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Baron, A. Binder, N. Attal, R. Casale, A. H. Dickenson, and R.-D. Treede, “Neuropathic low back pain in clinical practice,” European Journal of Pain, vol. 20, no. 6, pp. 861–873, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. R.-D. Treede, T. S. Jensen, J. N. Campbell et al., “Neuropathic pain: redefinition and a grading system for clinical and research purposes,” Neurology, vol. 70, no. 18, pp. 1630–1635, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Cruccu and A. Truini, “Tools for assessing neuropathic pain,” PLoS Medicine, vol. 6, no. 4, Article ID e1000045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. S. Titelbaum, J. L. Frazier, R. I. Grossman et al., “Wallerian degeneration and inflammation in rat peripheral nerve detected by in vivo MR imaging,” American Journal of Neuroradiology, vol. 10, no. 4, pp. 741–746, 1989. View at Google Scholar
  5. G. A. Grant, G. W. Britz, R. Goodkin, J. G. Jarvik, K. Maravilla, and M. Kliot, “The utility of magnetic resonance imaging in evaluating peripheral nerve disorders,” Muscle & Nerve, vol. 25, no. 3, pp. 314–331, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. K. E. Chappell, M. D. Robson, A. Stonebridge-Foster et al., “Magic angle effects in MR neurography,” American Journal of Neuroradiology, vol. 25, no. 3, pp. 431–440, 2004. View at Google Scholar
  7. R. A. Autio, J. Karppinen, M. Kurunlahti, E. Kyllönen, H. Vanharanta, and O. Tervonen, “Gadolinium diethylenetriaminepentaacetic acid enhancement in magnetic resonance imaging in relation to symptoms and signs among sciatic patients,” Spine, vol. 27, no. 13, pp. 1433–1437, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. el Barzouhi, C. L. Vleggeert-Lankamp, G. J. L. à Nijeholt et al., “Reliability of gadolinium-enhanced magnetic resonance imaging findings and their correlation with clinical outcome in patients with sciatica,” Spine Journal, vol. 14, no. 11, pp. 2598–2607, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. K. E. Jacobs, D. Behera, J. Rosenberg et al., “Oral manganese as an MRI contrast agent for the detection of nociceptive activity,” NMR in Biomedicine, vol. 25, no. 4, pp. 563–569, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Vasudeva, K. Andersen, B. Zeyzus-Johns et al., “Imaging neuroinflammation in vivo in a neuropathic pain rat model with near-infrared fluorescence and 19F magnetic resonance,” PLoS One, vol. 9, no. 2, Article ID e90589, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Ghanouni, D. Behera, J. Xie, X. Chen, M. Moseley, and S. Biswal, “In vivo USPIO magnetic resonance imaging shows that minocycline mitigates macrophage recruitment to a peripheral nerve injury,” Molecular Pain, vol. 8, no. 1, p. 49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. L. J. Thorek, A. K. Chen, J. Czupryna, and A. Tsourkas, “Superparamagnetic iron oxide nanoparticle probes for molecular imaging,” Annals of Biomedical Engineering, vol. 34, no. 1, pp. 23–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Bendszus and G. Stoll, “Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging,” Journal of Neuroscience, vol. 23, no. 34, pp. 10892–10896, 2003. View at Publisher · View at Google Scholar
  14. L. Josephson, J. M. Perez, and R. Weissleder, “Magnetic nanosensors for the detection of oligonucleotide sequences,” Angewandte Chemie, vol. 113, no. 17, pp. 3304–3306, 2001. View at Publisher · View at Google Scholar
  15. J. M. Perez, T. O’Loughin, F. J. Simeone, R. Weissleder, and L. Josephson, “DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents,” Journal of the American Chemical Society, vol. 124, no. 12, pp. 2856-2857, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Perez, L. Josephson, T. O’Loughlin, D. Högemann, and R. Weissleder, “Magnetic relaxation switches capable of sensing molecular interactions,” Nature Biotechnology, vol. 20, no. 8, pp. 816–820, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Zhao, L. Josephson, Y. Tang, and R. Weissleder, “Magnetic sensors for protease assays,” Angewandte Chemie International Edition, vol. 42, no. 12, pp. 1375–1378, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Schellenberger, F. Rudloff, C. Warmuth, M. Taupitz, B. Hamm, and J. Schnorr, “Protease-specific nanosensors for magnetic resonance imaging,” Bioconjugate Chemistry, vol. 19, no. 12, pp. 2440–2445, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Veiseh, J. W. Gunn, and M. Zhang, “Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging,” Advanced Drug Delivery Reviews, vol. 62, no. 3, pp. 284–304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Dev, P. K. Srivastava, J. P. Iyer, S. G. Dastidar, and A. Ray, “Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain,” Expert Opinion on Investigational Drugs, vol. 19, no. 4, pp. 455–468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. M. Hughes, G. M. A. Wells, V. H. Perry, M. C. Brown, and K. M. Miller, “Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems,” Neuroscience, vol. 113, no. 2, pp. 273–287, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Wan, K. Yang, Q. E. Lim et al., “Identification and validation of reference genes for expression studies in a rat model of neuropathic pain,” Biochemical and Biophysical Research Communications, vol. 400, no. 4, pp. 575–580, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. R. Challa, “Surgical animal models of neuropathic pain: pros and cons,” International Journal of Neuroscience, vol. 125, no. 3, pp. 170–174, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. S. H. Kim and J. M. Chung, “An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat,” Pain, vol. 50, no. 3, pp. 355–363, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. L. A. Havton, “A lumbosacral ventral root avulsion injury and repair model for studies of neuropathic pain in rats,” Methods in Molecular Biology, vol. 851, pp. 185–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. P. J. Austin, A. Wu, and G. Moalem-Taylor, “Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats,” Journal of Visualized Experiments, no. 61, Article ID e3393, 2012. View at Publisher · View at Google Scholar
  27. L. Josephson, C.-H. Tung, A. Moore, and R. Weissleder, “High-efficiency intracellular magnetic labeling with novel superparamagnetic-tat peptide conjugates,” Bioconjugate Chemistry, vol. 10, no. 2, pp. 186–191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Hagemann, J. Anacker, R. I. Ernestus, and G. H. Vince, “A complete compilation of matrix metalloproteinase expression in human malignant gliomas,” World Journal of Clinical Oncology, vol. 3, no. 5, pp. 67–79, 2012. View at Publisher · View at Google Scholar
  29. W. Li, J. Li, Y. Wu et al., “A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408),” Journal of Medicinal Chemistry, vol. 52, no. 7, pp. 1799–1802, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. R. E. Schmidt and S. B. Plurad, “Ultrastructural appearance of intentionally frustrated axonal regeneration in rat sciatic nerve,” Journal of Neuropathology and Experimental Neurology, vol. 44, no. 2, pp. 130–146, 1985. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Chandler, J. Cossins, J. Lury, and G. Wells, “Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-α fusion protein,” Biochemical and Biophysical Research Communications, vol. 228, no. 2, pp. 421–429, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Chelluboina, K. R. Nalamolu, J. D. Klopfenstein et al., “MMP-12, a promising therapeutic target for neurological diseases,” Molecular Neurobiology, vol. 55, no. 2, pp. 1405–1409, 2017. View at Publisher · View at Google Scholar · View at Scopus
  33. S.-i. Matsumoto, T. Kobayashi, M. Katoh et al., “Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits,” American Journal of Pathology, vol. 153, no. 1, pp. 109–119, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Liefner, B. Maruschak, and W. Bruck, “Concentration-dependent effects of pentoxifylline on migration and myelin phagocytosis by macrophages,” Journal of Neuroimmunology, vol. 89, no. 1-2, pp. 97–103, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Jiang, H. Li, Y. Sun et al., “Differential gene expression in proximal and distal nerve segments of rats with sciatic nerve injury during Wallerian degeneration,” Neural Regeneration Research, vol. 9, no. 12, pp. 1186–1194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Kobayashi and S. Kishioka, “Matrix metalloprotease 12 is a novel prospective molecule regulating neuropathic pain,” Pain Research, vol. 30, no. 1, pp. 37–45, 2015. View at Publisher · View at Google Scholar
  37. J. Park, J. Yang, E.-K. Lim et al., “Anchored proteinase-targetable optomagnetic nanoprobes for molecular imaging of invasive cancer cells,” Angewandte Chemie International Edition, vol. 51, no. 4, pp. 945–948, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Gallo, N. Kamaly, I. Lavdas et al., “CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imaging,” Angewandte Chemie International Edition, vol. 53, no. 36, pp. 9550–9554, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Ansari, G. A. Tikhomirov, S. H. Hong et al., “Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy,” Small, vol. 10, no. 3, pp. 566–575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Gandhi, H. Arami, and K. M. Krishnan, “Detection of cancer-specific proteases using magnetic relaxation of peptide-conjugated nanoparticles in biological environment,” Nano Letters, vol. 16, no. 6, pp. 3668–3674, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. N. H. Lim, E. Meinjohanns, G. Bou-Gharios et al., “In vivo imaging of matrix metalloproteinase 12 and matrix metalloproteinase 13 activities in the mouse model of collagen-induced arthritis,” Arthritis & Rheumatology, vol. 66, no. 3, pp. 589–598, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. X. J. Wáng and J.-M. Idée, “A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging,” Quantitative Imaging in Medicine and Surgery, vol. 7, no. 1, pp. 88–122, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. J. M. Perez, L. Josephson, and R. Weissleder, “Use of magnetic nanoparticles as nanosensors to probe for molecular interactions,” ChemBioChem, vol. 5, no. 3, pp. 261–264, 2004. View at Publisher · View at Google Scholar · View at Scopus